The American Academy of Otolaryngic Allergy (AAOA) represents over 2,700 Board-certified otolaryngologists and health care providers. Otolaryngology, frequently referred to as Ear, Nose, and Throat (ENT), uniquely combines medical and surgical expertise to care for patients with a variety of conditions affecting the ears, nose, and throat, as well as commonly related conditions. AAOA members devote part of their practice to the diagnosis and treatment of allergic disease. The AAOA actively supports its membership through education, research, and advocacy in the care of allergic patients.
"Advance the comprehensive management of allergy and inflammatory disease in Otolaryngology-Head and Neck Surgery through training, education, and advocacy."
As part of our on-going member support, we are introducing a new website feature to help with common practice management challenges. We welcome your input with questions or challenges you would like to address. Read More
Implementation of the new USP General Chapter <797> Pharmaceutical Compounding — Sterile Preparations is still…
As AMA reported in the AMA Advocacy Update of May 22, HHS announced that providers need to…
The Department of Health and Human Services (HHS) announced how it plans to allocate the…
12/01/25: Research Grant Cycle
Learn more
06/01/26: Fellow Exam Application Deadline
Learn more
06/01/26: Research Grant Cycle
Learn more
08/08/26: Scientific Abstract Submission Deadline
Learn more
Focusing on surgical and medical management of airway disease in ENT, the Explorers Course 2026 will focus on the "sinus” headache, ocular manifestations of allergies and treatments beyond antihistamine eye drops, food allergy, microbiome and allergies/sinusitis, changing environment, and more. Learn about the Explorers Course 2026 here.
We are pleased to invite you to participate in the 2026 AAOA Annual Meeting Call for Proposals. Do you have burning content ideas to be presented at the Annual Meeting? The AAOA is seeking proposals to incorporate in the educational sessions for the 2026 Annual Meeting. Learn More
For information about Resident membership, opportunities, DosedDaily, research grants, and other resources. Learn More
IFAR Impact Factor: 2.454
IFAR Featured Content: COVID-19 - Free Access
Endonasal instrumentation and aerosolization risk in the era of COVID‐19: simulation, literature review, and proposed mitigation strategies . Read More
Explorers Course 2026:
Surgical & Medical Management of Airway Disease in Otolaryngology — Hybrid
90-days Access December 22-March 23, 2026
January 22-24, 2026 - Live
Fairmont Sonoma Mission Inn & Spa,
Sonoma, CA
Learn More and Register
2026 AAOA Basic Course in Allergy & Immunology – Hybrid
90-days Access June 9– Sep 14, 2026
July 9-11, 2026 – Live
The Diplomat, Hollywood, Florida
Learn More and Register
USP 797 Online Module
Learn More and Register
AAOA Educational Stacks
Available October 1 - December 31, 2025
Bruce A. Scott, MD is talking about physician payment on CBS News Detroit. Bruce A…
“The color of springtime is in the flowers, the color of winter is in the…
Thanks to your feedback, we have reimagined our Advanced Course in Allergy & Immunology to…
The American Academy of Otolaryngic Allergy (AAOA) Practice Resource Tool Kit is intended as a guide to help AAOA members integrate allergy into their otolaryngology practice and to continually improve on this integration as new information, regulations, and resources become available.
AAOA has launched a Partner Resource Center to bring you partner resources that can assist your practice and patient care.
Now at the end of 2020, we embark on another year with the AAOA, but with significant and obvious changes. As an organization, we strive to continue to serve the membership with both education and tools necessary to treat allergic…
Dear Colleagues, I hope all of you enjoyed our spectacular record-setting annual meeting with over 500 registered attendees this year. I wish we could have connected in person in Scottsdale; however, this year has brought unprecedented challenges to everyone due…
House Speaker Nancy Pelosi (D-CA) and Treasury Secretary Steven Mnuchin appeared to be moving closer to a deal on a fourth major COVID-19 relief bill before the election—they were approximately $300 billion apart on a package. However, the results of…
By Rob Stachler, MD, FAAOA Choosing between sublingual immunotherapy (SLIT) and subcutaneous immunotherapy (SCIT) can often be a very difficult decision. We are told that the allergy shots are “covered” by our insurance. We are often lulled into a false…
By Alfred M. Sassler, DO, FAAOA, FACS Many people with seasonal allergies know they are sensitive to pollens that increase and decrease in prevalence at different times of the year depending on the climate where they live. Sometimes called “Hay…
Alpen Patel, MD, FAAOA on changes caused by the COVID-19 pandemic and AAOA member resources and virtual events. https://youtu.be/_Cn-vmrR3OQ If you have any questions or feedback, please contact AAOA at (202) 955-5010 or email to membership@aaoallergy.org. COVID-19 Resources Resuming SCIT…
On August 3, the Centers for Medicare & Medicaid Services (CMS) released the Medicare Physician Fee Schedule (MPFS) proposed rule for CY 2021. This proposal updates payment policies and payment rates for Part B services furnished under the MPFS, as…
By James Connolly, MD, FAAOA Allergic rhinitis is caused by many different antigens. Some antigen exposure seasonal (limited exposure during the year such as ragweed or tree pollen), and some antigen exposure is year around or perennial, such as dust…
In the second episode of the AAOA's NEW podcast series Today in ENT Allergy: AAOA's Podcast, Jennifer Villwock, MD, FAAOA speaks with the AAOA's current Presedent (2019-2020) Alpen Patel, MD, FAAOA. They are discussing the integral role allergy plays in…
Release Date: August 14, 2020; Expiration Date: August 13, 2021 Nasal polyps impact an estimated 13 million Americans. In particular, nasal polyps affect 45% of people with adult-onset asthma and approximately 30% of people with chronic rhinosinusitis, in the latter,…
